key: cord-1016323-76hwmd7p
authors: Rouadi, Philip W.; Idriss, Samar A.; Bousquet, Jean; Laidlaw, Tanya M.; Azar, Cecilio R.; Sulaiman AL-Ahmad, Mona; Yáñez, Anahí; AL-Nesf, Maryam Ali Y.; Nsouli, Talal M.; Bahna, Sami L.; Abou-Jaoude, Eliane; Zaitoun, Fares H.; Hadi, Usamah M.; Hellings, Peter W.; Scadding, Glenis K.; Smith, Peter K.; Morais-Almeida, Mario; Gómez, R. Maximiliano; González Díaz, Sandra N.; Klimek, Ludger; Juvelekian, Georges S.; Riachy, Moussa A.; Canonica, Giorgio Walter; Peden, David; Wong, Gary W.K.; Sublett, James; Bernstein, Jonathan A.; Wang, Lianglu; Tanno, Luciana Kase; Chikhladze, Manana; Levin, Michael; Chang, Yoon-Seok; Martin, Bryan L.; Caraballo, Luis; Custovic, Adnan; Ortega-Martell, José Antonio; Jensen-Jarolim, Erika; Ebisawa, Motohiro; Fiocchi, Alessandro; Ansotegui, Ignacio J.
title: WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways()
date: 2021-12-04
journal: World Allergy Organ J
DOI: 10.1016/j.waojou.2021.100617
sha: 9e5889ea9312a3ac6c7abd29237d2bb0dc30a49c
doc_id: 1016323
cord_uid: 76hwmd7p

BACKGROUND: Cough features a complex peripheral and central neuronal network. The function of the chemosensitive and stretch (afferent) cough receptors is well described but partly understood. It is speculated that chronic cough reflects a neurogenic inflammation of the cough reflex, which becomes hypersensitive. This is mediated by neuromediators, cytokines, inflammatory cells, and a differential expression of neuronal (chemo/stretch) receptors, such as transient receptor potential (TRP) and purinergic P2X ion channels; yet the overall interaction of these mediators in neurogenic inflammation of cough pathways remains unclear. OBJECTIVES: The World Allergy Organization/Allergic Rhinitis and its Impact on Asthma (WAO/ARIA) Joint Committee on Chronic Cough reviewed the current literature on neuroanatomy and pathophysiology of chronic cough. The role of TRP ion channels in pathogenic mechanisms of the hypersensitive cough reflex was also examined. OUTCOMES: Chemoreceptors are better studied in cough neuronal pathways compared to stretch receptors, likely due to their anatomical overabundance in the respiratory tract, but also their distinctive functional properties. Central pathways are important in suppressive mechanisms and behavioral/affective aspects of chronic cough. Current evidence strongly suggests neurogenic inflammation induces a hypersensitive cough reflex marked by increased expression of neuromediators, mast cells, and eosinophils, among others. TRP ion channels, mainly TRP V1/A1, are important in the pathogenesis of chronic cough due to their role in mediating chemosensitivity to various endogenous and exogenous triggers, as well as a crosstalk between neurogenic and inflammatory pathways in cough-associated airways diseases.

Persistent coughing lasting for 8 weeks in adults 1 or 4 weeks in children [2] [3] [4] can be defined as chronic cough, although prolonged acute cough can persist for 3 to 8 weeks in children. 3 The physiologic cough reflex has well-defined vagus nerve-mediated afferent and efferent neuroanatomical and signal pathways. [5] [6] [7] [8] [9] [10] [11] The peripheral afferent cough receptors, namely the chemosensitive and stretch receptors, are selectively distributed along the airways. They also manifest different triggers and functions (Table 1) . Current research suggests that stimulation of these hyperreactive afferent vagus nerve endings can result in chronic cough, the so-called hypersensitive cough reflex (HCR). 12 HCR manifests as variable lower than normal trigger thresholds to cough in various inflammatory and non-inflammatory airways pathologies and gastroesophageal refluxrelated diseases. These trigger thresholds can be assessed by topical and inhalation tussigen challenges. HCR, however, can also occur in the absence of known triggers. Based on clinical models, it is speculated the underlying mechanism of HCR is a concomitant neurogenic and inflammatory pathological alteration of the cough reflex which becomes hypersensitive. 13 Moreover, HCR in different anatomical regions is associated with a plethora of biomarkers which can be expressed individually or act collectively. These encompass neuronal receptors such as transient receptor potential (TRP) and purinergic P2X ion channels, 14, 15 exogenous and endogenous neuromediators, 16, 17 and cytokines and inflammatory cells. 18 The current part I of the consensus (see Appendix) examines the neuroanatomical pathways, pathogenic mechanisms, and the role of TRP ion channels in modulation of chronic cough. The different phenotypes of abnormal cough presentation and their management will be published subsequently in part II and III of the consensus, respectively.

Cough reflex entails a physiological halt of the central "respiratory generator pattern" of normal respiration, in parallel with activation of the medullary premotor and motor neuronal pathways which initiate cough, collectively called the "cough generator pattern". 19 Peripheral afferent cough pathway Two parallel vagal afferent pathways of cough reflex originate in the nodose and the jugular ganglia. These have different embryological origins 20 and distinct peripheral anatomical distributions (see Table 1 ) at which therapeutic trials are directed when investigating chronic cough. This approach is collectively called the "anatomic-diagnostic protocol" for cough management. 5 Chemoreceptors Both jugular and nodose ganglia have chemosensitive (nociceptive) neurons which are unmyelinated C fibers, mainly sensitive to chemical stimuli and lung inflation (Table 1) . These chemoreceptors are associated with TRP ion channels, constitute the majority of airway afferent neurons in the lung and nose 6 and innervate the lower respiratory tract from the larynx to alveoli. Their activation causes airway constriction and mucus secretion, cough, and sneezing. The serious signs and symptoms of apnea, bradycardia, and hypotension can also be activated via these ganglia. 6 Data suggest that chemoreceptors (eg, TRP-Vanilloid-1) are stretchinsensitive; 21 however, they can also act as high threshold mechanoreceptors 8 when activated by severe mechanical stimuli such as lung hyperinflation and aggressive touch stimuli. Despite lack of solid evidence, a "two pathways model" of cough has been suggested, whereby jugular chemo-sensitive receptors initiate cough in the proximal airways, whereas nodose chemosensory activation in the distal airways can inhibit cough. 22, 23 This is based on the fact that some mediators such as the cellular breakdown byproduct adenosine triphosphate (ATP) and serotonin, both of which are selective activators of nodose-chemosensitive neurons, are not potent tussigens. In summary, chemoreceptors can have a dual tussive role in view of their high sensitivity (low threshold) to inhaled chemicals, but also low activation (high threshold) by severe mechanical stimuli.

Nodose ganglia, but not jugular ganglia, incorporate stretch (mechanical) receptors which can be rapidly-(RARs) or slowly-(SARs) adapting stretch receptors and are present mainly in the distal airways 6 ( Table 1) . Their main function is protecting the airways from generally aspirated or inhaled matter. 8 Stretch receptors are relatively insensitive to a wide range of chemical stimuli, 8, 24 although data to the contrary exist. 25 RARs are mainly intrapulmonary dynamic receptors triggered by change in intrapulmonary airway mechanical properties, namely diameter, length, and interstitial pressures. 6 Their activation triggers parasympathetically-mediated reflex bronchospasm and mucus secretion. The act of coughing and subsequent gasping inhalation can provoke RAR-stretch receptors and a pathogenic amplification loop. Contrary to their role in promoting bronchospasm, RARs can also attenuate cough. This is effected by counteraction of molecules which mediate bronchospasm in end organs, such as substance P and bradykinin, histamine, and capsaicin. 6 This adds to the complexity of chronic cough. Similarly, bronchodilating agents such as prostaglandin (PG) E2, adrenaline, and adenosine can have a dual role. They can inhibit bronchospasm secondary to activation of RARstretch receptors by capsaicin and bradykinin. However, bronchodilators can also sensitize C fiber-chemoreceptors to capsaicin and bradykinin thereby promoting cough and bronchospasm. 26, 27 SARs are incorporated within the bronchioles and alveoli 6 and have peak activity at end-inspiration when they initiate normal expiration through a centrally mediated inhibition of muscarinic respiratory drive. 5 It is questionable whether SARs, RARs, or both contribute to the bronchoprotective (bronchodilating) effect of deep inspiration. 28 The latter normally becomes suppressed in healthy subjects undergoing methacholine bronchoprovocation challenge. 29 Nevertheless, stretch receptors can promote coughing through central activity at the level of the brainstem. In summary, stretch receptors initiate physiologic expiration and additionally can either trigger or attenuate cough by different pathogenic mechanisms.

Mechano-receptors originating from nodose ganglia and carried by the vagus nerve can overlap with jugular chemo-sensory terminals in the proximal airways (Table 1) . Thus, the larynx, trachea, and main bronchi can be triggered by both mechanical and chemical stimuli. 6 However, it is generally agreed stretch receptors are not activated by chemical stimuli except when mechanical distortion of nerve terminal occurs. This can be secondary to mucosal inflammation, mucus secretion, or alteration in smooth muscle tone. 24, 30 Based on animal studies, this overlapping subpopulation of nodose-stretch receptors and jugular-chemoreceptors is sensitive to rapid changes of pH and touch-like stimuli, hence their partial role in clearing the airways specifically from aspiration of food or gastric contents. 22, 31 Taken all together, these data indicate chemoreceptors are overabundant in the respiratory tract and overlap anatomically with stretch receptors. They normally trigger the cough reflex as opposed to stretch receptors which can promote or attenuate coughing. Chemoreceptors can have variable Overlap with chemoreceptors Table 1 . Neuro-anatomical properties and functional role of cough chemosensitive and stretch receptors in vagal afferent neuronal pathways from human and animal clinical models. SARs (slow adapting receptors), RARs (rapid adapting receptors), *chemoreceptors can act as high threshold mechano (stretch) receptors, bronchoconstriction, cough and mucus secretion, o Respiratory drive blockage and initiation of expiration thresholds to a range of chemical agents including those which trigger stretch receptors.

Centrally the afferent pathways of the nodose and jugular ganglia feature different brainstem projections, namely the nucleus solitarius and paratrigeminal nucleus, respectively 32-34 (Fig. 1 ). Central cough mechanisms and specific regions involved are unknown. Moreover, ascending pathways from the brainstem to higher cortical areas can be studied with functional brain imaging. 35, 36 This imaging helps us understand the behavioral, sensory-discriminative, and affective-motivational aspects of airway irritation. 37 Central descending pathways of the prefrontal cortical region are involved with urge-to-cough and the initiation of a voluntary cough or its suppression; this occurs in the presence or absence of a peripheral activation stimulus. 38 For example, chronic cough patients were less able to suppress cough in response to capsaicin inhalation, when compared to healthy controls, reportedly due to failure of inhibitory descending pathways. 39 In accordance, patients with chronic cough challenged with sufficient inhaled capsaicin to induce urge-to-cough demonstrated lower activation of cough inhibitory descending pathways by functional magnetic resonance imaging, compared to healthy subjects. 40 Upregulation or downregulation of cough can occur centrally or peripherally. Central modulation of cough can be manifested by voluntary suppression of cough. 37 Both central and peripheral modulation of cough are likely independent of a systemic airway inflammatory disease. This can partly explain the controversial role of atopy as a risk factor for chronic cough in the lower airways. 41 In summary, central cough pathways account for behavioral/affective aspects of cough in addition to modulation of tussive effect as manifested by inhibition or suppression of voluntary cough and urge-to-cough. This is likely independent of a systemic airway inflammation.

HCR is best described as a hyperexcitable neuroinflammation of the cough-triggering vagal neuronal pathway. This can occur centrally, 42 peripherally or both, 37, 43 and is mediated by increased neuronal expression of TRP ion channels. 44 Triggers, which in otherwise normal individuals do not necessarily exacerbate cough, can cause prolonged coughing in patients with HCR (Fig. 1) . These triggers include normal human activity, changes in ambient atmospheric conditions, exposure to airborne irritants and pollutants, an acute infectious or atopic respiratory event, and a chronic inflammatory disease as well as with an experimental inhalation challenge with tussigens. 

Various triggers can induce acute, subacute, or chronic modification of excitability pattern in the cough central and likely afferent neuronal pathway along the vagus nerve. This can result in exaggeration or suppression of cough reflex, a term called cough plasticity. Cough plasticity can be modified by the following factors: 1) the nature of triggering factors, 2) the ensuing modification in intrinsic neuronal excitability, 3) changes in neuronal synaptic transmission (pre-or postsynaptic), and 4) the subsequent effect of neurotransmitters and neuromodulators, such as the calcitonin gene-related peptide (CGRP), 45 an important neuropeptide with pro-inflammatory potential. Evidence suggests that cough plasticity involves primarily the (vagal) nucleus tractus solitarius, 19 the associated higher central sensory processing circuit 46 and the vagal afferent nerves. 47 Also, it is speculated this abnormal excitability of central sensory neuronal pathways can exist even in the absence of a prior acute or chronic peripheral sensitization; this is very similar to chronic neuropathic pain which results in the "uncoupling of central cough hypersensitivity state to the injury zone". 48 In summary, cough plasticity refers to a peripheral/central variable cough threshold to nonspecific triggers, or their absence, and is driven partly by neurogenic mechanisms involving neuropeptides and neuromodulators, among others.

In HCR, the term "neurogenic inflammation" implies cough is primarily a neurogenic response monitored by the immune system. Dysfunction of one or both systems can result in HCR. 49 Direct or indirect release of inflammatory mediators has been reported into the nucleus tractus solitarius and adjacent medullary neuronal complex area. 19 The intricate regulatory role of the immune system in HCR is deciphered by experimental in-vivo and in-vitro models comparing different cough phenotypes to each other or to healthy individuals. Based on specimen findings from broncho-alveolar lavage fluid, induced sputum and lung biopsies of patients with different cough phenotypes, 43 studies suggest inflammatory cells such as eosinophils, neutrophils and mast cells are involved in the pathogenesis of cough. In fact, there is a considerable similarity in biochemical profile among patients with HCR (see below). A detailed description of immune cascade pathways in HCR is comprehensively described elsewhere. 43, 49, 50 Importantly, in vivo and in vitro data from these reviews address the immune modulatory role of cough in a variety of lower airway clinical phenotypes of chronic cough but unfortunately most patient populations included in these studies are small in size. Neurokinins such as substance P, CGRP, and interleukins (IL)-4 and IL-5 stimulate eosinophils to release effector molecules such as major basic proteins, cysteinyl leukotrienes, and eosinophil granule-derived cationic proteins with resultant stimulation of cough sensory and muscarinic nerves. 12, 43 Nerve growth factor (NGF), whose main source in humans is eosinophils, increases expression of TRP channels (TRPV1, TRPA1) on sensory nerves with inflammation, thus highlighting the role of allergic airway inflammation in chronic cough. 21,51,52 Similar modulation of cough can also be induced by IL-17-mediated infiltration of neutrophils whose probable role in neurogenic inflammation is generation of reactive oxygen species and sensitization of cough neuronal pathway. The same effect can result from bradykinin-induced secretion of PGs 43 which are potent tussigens. 12 Data also suggest an important role of mast cells in chronic cough patients. Patients with non-asthmatic cough have marked submucosal mast cell infiltration as opposed to patients with asthmatic cough with submucosal infiltration by neutrophils and eosinophils. 53 CGRP, a byproduct of neurogenic inflammation of sensory nerves, induces mast cell hyperplasia. 54, 55 These cells, which are in close association with airway mucosal sensory nerves, highlight the role of the innate immune system in regulating neurogenic inflammation in respiratory epithelium of chronic cough patients. 54 For example, increase in histamine and PGD2 in sputum specimens of patients with non-asthmatic eosinophilic bronchitis compared to asthmatics suggests that mast cell are particularly activated in the former cough phenotype. 56 Meanwhile, data from clinical trials using biological therapy undermine the role of eosinophils in HCR. For example, anti-IL-5 treatment improved cough scores in asthmatics, but not markers of sputum eosinophilia. This speculates a more important role of mast cells in asthmatic patients with cough. 57 Along the same line, inhaled and nasal topical steroids improved markers of eosinophilic inflammation in cough-associated asthma/eosinophilic bronchitis, and allergic rhinitis/chronic rhinosinusitis with nasal polyps, respectively. 50 Taken together, these data and others suggest airway eosinophilia can be an epiphenomenon in chronic cough, yet maintain evidence that eosinophilic airway inflammation identifies steroid-responsive patients. 58 Other neuroinflammatory mediators implicated in HCR 59 such as IL-1b, tumor necrosis factor-a and NGF have an integral role in TRPV1 and TRPA1 gene production and channel expression. [60] [61] [62] In conclusion, despite ample evidence of inflammatory and biochemical mediators of neurogenic inflammation being involved in different cough phenotypes, their exact role remains obscure. There seems to be an important role of mast cells and innate immune system in HCR. Yet, it is difficult to clearly delineate the signal and cascade pathways involved in different etiologies or phenotypes of chronic cough.

Neuro-physiological properties TRP channels are a collective family of ion channel receptors located at afferent airway cough neurons of the vagus and trigeminal nerves and mediate airway protective mechanisms to noxious stimuli 21 (Fig. 1) . They are present in the entire respiratory tract from the nose through to the alveoli and are expressed on neuronal and nonneuronal cells such as epithelium, fibroblasts, smooth muscle cells, and inflammatory cells. TRP expression on smooth muscle cells suggests their role also in mediating structural and functional changes in airway mucosal barrier as occurs, for example, in airway remodeling. 21 Broadly speaking, TRPV1 (aka capsaicin receptor) and TRPA1 dominate the intra-and extra-pulmonary cough airway afferents, are carried on unmyelinated C fibers, and are chemosensitive, that is triggered by locally produced or inhaled chemicals and inflammatory mediators. On the other hand, airway sensitivity to mechanical, thermal, and pHrelated stimuli is generally featured on a minority of airway cough afferents which are almost exclusively extrapulmonary (proximal airways), are carried on myelinated A-d fibers, and are not mediated by TRPV1 channels.

A thorough anatomical and functional description of TRP channels in different cough phenotypes is well described in the literature 14, 21, 63 and summarized in Table 2 . Chemoreceptors are the main TRP channels featured in the airways and are, in the majority, TRPV1 ion channels. These co-localize with neuropeptides, such as substance P, CGRP, and receptors for NGF. They also have low threshold for various inflammatory mediators such as bradykinins, histamines and eicosanoids. 11 Simultaneous stimulation by multiple TRP channel agonists, such as occurs with capsaicin in the presence of gastric acid 11 or fever, 64 can further lower the activation threshold. In accordance, the simultaneous activations of TRPA1 and TRPV1 by their respective selective agonists on pulmonary sensory nerves are far more effective than single agonists taken separately. 65 Chemosensitivity of TRPV1 and TRPA1 to endogenously generated chemicals such as bradykinin, arachidonic acid, and its effector, PGE2, coupled to G protein receptor activation 21,66 occurs in inflammatory diseases, such as asthma. Oxidative stress mediators following exposure to air pollutants, such as cigarette smoke (acrolein), diesel exhaust particles, aldehydes, chlorines, and scents, can also trigger chemosensitive TRPA1 channels. Both TRPV1 and TRPA1 activate the mucinproducing MUC5 gene. 67 In mammal models, a calcium mediated activation of TRP channels triggers local release of neuropeptides from afferent terminals peripherally or centrally. Ultimately, a signal is sent through efferent cholinergic pathways to cause bronchoconstriction in parallel with a vagal motor neuron-mediated signal to the larynx, accessory respiratory muscles and diaphragm to initiate cough and induction of various cellular responses. 14 In summary, current data suggest airway chemosensitivity to endogenously produced and/or exogenously inhaled chemicals and inflammatory products is mediated by TRP-A1/V1 channels. Central and peripheral mechanisms subsequently induce bronchoconstriction and cough. Cough phenotypes -Allergic rhinitis, -Asthma, -COPD.

-Asthma, -COPD. 14 -Asthma, -COPD. 141 -Cold induced-nasal hyperreactivity, -Cough and bronchoconstriction, -COPD. 51 , 133 , 142 -Asthma, -COPD. 38 Table 2 . Role in neurogenic inflammation, polymorphism, and cough suppression

As described earlier, TRP channels mediate neurogenic inflammation. They can respond differentially to inflammatory mediators and, through Ca-dependent mechanisms, can produce additional mediators. For example, stimulation of TRPV1 and TRPA1 can locally release neurotrophins important for chemotaxis and activation of eosinophils. Once activated, eosinophils secrete NGF resulting in recycling of TRP channels to surface membrane 60,68 and increased expression of TRP channels resulting in an amplification loop. 11 Ultimately, depolarization or hyperpolarization of TRP channels at nerve terminals can respectively increase or decrease excitability of cough afferent neuronal pathway. This crosstalk between inflammatory and neurogenic signal pathways highlights the role of TRP channels in several airway diseases. These can include post-viralcough, idiopathic cough, asthma, and chronic obstructive pulmonary disease, and other less frequent respiratory diseases such as idiopathic pulmonary fibrosis and airway Pseudomonas infection in cystic fibrosis. 21 This same cross talk likely also occurs in COVID-19 cough. 69, 70 Due to their variable expression patterns in neurogenic inflammation, it is also suggested that TRP channels may be partly responsible for a transition from early (acute) defensive immune and inflammatory responses to chronic responses and chronic cough pathology. 21 Unlike other TRP channels, TRPM8 can mediate a decrease in capsaicin-mediated cough sensitivity in the presence of thymol and camphor, which explains the antitussive effect of these agents, 71, 72 probably secondary to stimulation of cool receptors in the nasal cavity. 73,74 TRP channel variants have been linked to altered cough presentation: TRPV1 polymorphisms have been associated with decreased wheezing in a group of asthmatics 75 but a higher risk of chronic cough in both smokers and patients with occupational exposure. 76 Other data suggest that TRPA1 polymorphism is associated with poor control of asthma secondary to air pollutant (particulate matter) exposure. 77 Moreover, cough suppression can be mediated by TRP channels. Oral capsaicin was found to reduce cough by desensitization of TRPV1. 78 Also, TRPA1 antagonist suppressed cough in guinea pigs yet TRPV1 79 or TRPA1 antagonists 80 failed to suppress chronic cough in humans. This argues for involvement of central sensitization in HCR. In fact, data from P2X3 antagonists (see below) suggest central rather than peripheral neuronal pathways of vagus nerve are likely important target areas for new antitussive drug development. 81 In conclusion, the anatomical and physiological mapping of TRP channels along cough neuronal pathways and their upregulation in neurogenic inflammation of cough reflex suggest their important role in pathogenesis of chronic cough. This is likely manifested by a crosstalk between neurogenic and inflammatory signal pathways in coughassociated airway diseases.

P2X3 purinergic channels are receptors belonging to the P2X family of ion channels, with high predilection to the cellular breakdown product ATP. 82 P2X3 channels are almost exclusively expressed on sensory neurons. 83 Specifically, they are present, in their majority, on both C (chemoreceptors) and A-d fibers (mechanoreceptors) of vagal afferent cough pathways with some expression in nucleus tractus solitarius. 84 P2X3 receptor activation by adenosine triphosphate (ATP) depolarizes the peripheral cough neuronal pathway and transmits a central signal interpreted as urge-to-cough. 85 P2X3 channels can also modulate the cough neuronal pathway activity at central synapses in both upper and lower airways, hence the effect of P2X3 antagonists. 15 Mounting evidence suggests that P2X3 receptors can mediate HCR leading to chronic cough. 81 However, it remains unclear if the role of P2X3 in HCR is secondary to increased ATP production in the airways or decreased ATP degradation, an enhanced sensitivity to ATP or a combination of these factors. 86 SUMMARY This paper represents a comprehensive and updated review on neuroanatomy and pathophysiology of HCR, including novel findings on the role of TRP receptors and P2X channels in modulating chronic cough. Knowledge of immune pathways involved in chronic cough is vital to understand how neurogenic inflammation of HCR, in different anatomical regions of the aero-digestive tract, can express different symptomatology, and thus results in different cough-associated clinical phenotypes. In chronic cough, there is a differential expression of chemo/stretch-sensitive afferent receptors (TRP channels) as well as P2X ion channels. Also neuromediators and inflammatory cells, such as mast cells, eosinophils, and neutrophils, are involved in HCR. It is likely that mast cells and innate immune system have a pivotal role in HCR, whereas current data undermine the role of eosinophils in chronic cough. An important function of TRP channels in chronic cough stems from data on TRP polymorphism and cough suppression by TRP antagonists. TRP channels can also mediate cross talk between neurogenic and inflammatory signal pathways involved in chronic cough. The nature of cough triggers, spectrum of expressed TRP channels and their co-localization with distinct neuro-inflammatory mediators, in addition to tussigen challenge data, contribute significantly to a proper diagnosis and treatment strategies of chronic cough. Currently, we lack a better functional understanding of cough central pathways and how they modulate chronic cough. Tussigen challenge protocols which can better discriminate healthy subjects from patients with HCR need to be standardized. This is more evident considering the value and limitations of animal cough models. The rest of authors reviewed closely the whole article and added their valuable remarks.

Availability of materials Not applicable.

Ethics statement Not applicable. This is a consensus paper rather than research.

Not applicable.

Declaration of competing interest Jean Bousquet discloses financial relationships with the following entities: Purina, Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Sanofi-Aventis, Takeda, Teva, Uriach, KyoMed, MASK-air. Glenis Scadding discloses payment for talks from ALK, Bayer, GSK and Viatris. She is also chair/member of 3 Data Monitoring Committees for ALK. Jonathan A. Bernstein discloses he is PI and consultant and speaker for Merck. Erika Jensen-Jarolim discloses honoraria and support to attend meetings from Bencard Allergie, Germany, and Allergy Therapeutics Ltd, UK; a pending patent and stock or stock options with Biomedical Int. R þ D GmbH, Vienna; participation on data monitoring or advisory boards with Allergy Therapeutics Ltd, UK; and receipt of equipment, materials, drugs, medical writing, gifts or other services from Bencard Allergie, Germany. Giorgio Walter Canonica discloses speaker or advisory board roles with Menarini, Chiesi, Sanofi, GSK, AstraZeneca, Novartis, Stallergenes, Hall, Allergy Therapeutics. All other authors indicated they have nothing to disclose related to the submitted work.

Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report

A cough algorithm for chronic cough in children: a multicenter, randomized controlled study

Chronic cough in children

Differential diagnosis of chronic cough in children

Anatomy and neurophysiology of cough: CHEST guideline and expert panel report

Anatomy and neuro-pathophysiology of the cough reflex arc

Adenosine induces a cholinergic tracheal reflex contraction in Guinea pigs in vivo via an adenosine A1 receptor-dependent mechanism

An overview of the sensory receptors regulating cough

Chronic cough in subjects with upper airway diseases -analysis of mechanisms and clinical applications

Disorders of the lower cranial nerves

Rhinitis and Related Upper Respiratory Conditions -A Clinical Guide

Cough hypersensitivity syndrome: a few more steps forward

Approach to chronic cough: the neuropathic basis for cough hypersensitivity syndrome

Targeting TRP channels for chronic cough: from bench to bedside

The role of ATP in cough hypersensitivity syndrome: new targets for treatment

Cough in asthma

Interfering with airway nerves in cough associated with asthma

Increased neutrophils and cytokines, TNF-a and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough

Plasticity of brainstem mechanisms of cough

Viscerotopic Representation of the Upper alimentary tract in the rat : sensory ganglia and nuclei of the solitary and spinal Trigeminal Tracts

Airway Pathogenesis is linked to TRP channels. Emir

Identification of the tracheal and laryngeal afferent neurons mediating cough in anaesthetized Guineapigs

Opposing effects of bronchopulmonary C-fiber subtypes on cough in Guinea pigs

Multiple mechanisms of reflex bronchospasm in Guinea pigs

Vagal afferent innervation of the airways in health and disease

Epinephrine enhances the sensitivity of rat vagal chemosensitive neurons: role of b3-adrenoceptor

Afferent properties and reflex functions of bronchopulmonary C-fibers

Cough variant asthma: lessons learned from deep inspirations

The effect of deep inspiration on methacholine dose-response curves in normal subjects

Airway receptors

Mechanisms of acid-induced activation of airway afferent nerve fibres in Guinea-pig

Distinct brainstem and forebrain circuits receiving tracheal sensory neuron inputs revealed using a novel conditional anterograde transsynaptic viral tracing system

Evidence for multiple sensory circuits in the brain arising from the respiratory system: an anterograde viral tract tracing study in rodents

Anterograde neuronal circuit tracing using a genetically modified herpes simplex virus expressing EGFP

Investigation of the neural control of cough and cough suppression in humans using functional brain imaging

Representation of capsaicin-evoked urge-to-cough in the human brain using functional magnetic resonance imaging

Heterogeneity of cough neurobiology : clinical implications

Neural correlates of cough hypersensitivity in humans: evidence for central sensitisation and dysfunctional inhibitory control

Capsaicin-evoked cough responses in asthmatic patients: evidence for airway neuronal dysfunction

Central mechanisms of airway sensation and cough hypersensitivity

Immune system in the pathogenesis of chronic cough

Chronic cough hypersensitivity syndrome

Calcitonin gene-related peptide relates to cough sensitivity in children with chronic cough

Brain plasticity and ion channels

Plasticity of vagal afferent fibres mediating cough

Central sensitization: a generator of pain hypersensitivity by central neural plasticity

Cough hypersensitivity as a neuroimmune interaction

Cough and eosinophilia

Transient receptor potential (TRP) channels in the airway: role in airway disease

The emerging role of transient receptor potential channels in chronic lung disease

Upper airway cough syndrome in pathogenesis of chronic cough

Significance of conversation between mast cells and nerves

Nature of airway inflammation and remodeling in chronic cough

Induced sputum inflammatory mediator concentrations in chronic cough

Cough due to asthma and nonasthmatic eosinophilic bronchitis

Treatment of chronic asthma with prednisolone significance of eosinophils in the sputum

Are there clinical features of a sensitized cough reflex?

TNFa induces cotrafficking of TRPV1/TRPA1 in VAMP1-containing vesicles to the plasmalemma via Munc18-1/syntaxin1/SNAP-25 mediated fusion

NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels

Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-a after spinal nerve ligation

International union of basic and clinical pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family

Molecular and cellular limits to somatosensory specificity

Interaction between TRPA1 and TRPV1: synergy on pulmonary sensory nerves

Cough and airway disease: the role of ion channels

TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo

Recovery from tachyphylaxis of TRPV1 coincides with recycling to the surface membrane

Potential interplay between Nrf2 , TRPA1 , and TRPV1 in nutrients for the control of COVID-19

TRP channels in airway sensory nerves

Modulation of cough response by sensory inputs from the nose -role of trigeminal TRPA1 versus TRPM8 channels

thymol and camphor nasal challenges and their effect on nasal symptoms and cough in an animal model

Mechanisms of the placebo effect of sweet cough syrups

Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trial

Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma

Transient receptor potential genes, smoking, occupational exposures and cough in adults

Activation of transient receptor potential ankyrin-1 by insoluble particulate Material and Association with asthma

Cough reduction using capsaicin

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial

TRPA1 receptors in chronic cough

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study

Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death

Purinergic signalling and disorders of the central nervous system

Chronic cough

BLU-5937: a selective P2X3 antagonist with potent anti-tussive effect and no taste alteration

Mechanisms and rationale for targeted therapies in refractory and unexplained chronic cough

Translational review: neuroimmune mechanisms in cough and emerging therapeutic targets

Sensory nerves and airway irritability

Enhanced lung C-fiber responsiveness in sensitized adult Guinea pigs exposed to chronic tobacco smoke

Effect of inflammatory mediators prostaglandin E2 , bradykinin, and histamine

Ferrer-Montiel A. Bradykinin induces TRPV1 exocytotic recruitment in peptidergic nociceptors

The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil

Transient Receptor Potential (TRP) Cation Channels in Diabetes

The capsaicin receptor: a heat-activated ion channel in the pain pathway

Sensitization of TRPVI by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

TRPV1 and PLC participate in histamine H4 receptor-induced itch

Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H1 receptor and TRPV1

Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1

isolectin B4 binding in primary afferent neurons of the rat and mouse

An ice-Cold TR(i)P to skin biology: the role of TRPA1 in human epidermal keratinocytes

Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions

TRPA1 mediates formalin-induced pain

TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents

TRPA1 ion channel in the spinal dorsal horn as a therapeutic target in central pain hypersensitivity and cutaneous neurogenic inflammation

Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1

Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin

TRPV1 and TRPA1 function and modulation are target tissue dependent

The ion channel TRPA1 is required for chronic itch

Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization

Pre-clinical studies in cough research: role of transient receptor potential (TRP) channels

The trpv4 channel

Arachidonic acid-induced dilation in human coronary arterioles: convergence of signaling mechanisms on endothelial TRPV4-mediated Ca2þ entry

Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives

ATP P2X3 receptors and neuronal sensitization

Molecular mechanisms of human p2x3 receptor channel activation and modulation by divalent cation bound

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice

Role of transient receptor potential and pannexin channels in cigarette smoketriggered ATP release in the lung

Inhibition of citric acidand capsaicin-induced cough by novel TRPV-1 antagonist, V112220, in Guinea-pig

Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine

TRPV1 and TRPM8 in treatment of chronic cough

TRPV4: a multifunctional nonselective cation channel with complex regulation

Chemical and cold sensitivity of two distinct populations of TRPM8-expressing somatosensory neurons

P2X3 receptors and peripheral pain mechanisms

Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in Guinea pigs

Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity

What is the evidence for the role of TRP channels in inflammatory and immune cells?

Radial stretch reveals distinct populations of mechanosensitive mammalian somatosensory neurons

A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation

TRPV4 channels augment macrophage activation and ventilator-induced lung injury

Modulation of the TRPV4 ion channel as a therapeutic target for disease

The identification of the TRPM8 channel on primary culture of human nasal epithelial cells and its response to cooling. Med (United States

Human lung epithelial cells express a functional cold-sensing TRPM8 variant

TRPM8 channels: a review of distribution and clinical role

Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat

TRPV1 and TRPA1 in lung inflammation and airway hyperresponsiveness induced by fine particulate matter (PM2.5)

The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4þ T cells

TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice

Identification of the cold receptor TRPM8 in the nasal mucosa

Cellular distribution and functions of P2 receptor subtypes in different systems

Knocking out P2X receptors reduces transmitter secretion in taste buds

Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease

TRPM8 genetic variations associated with COPD risk in the Chinese Han population